AKT2 and neoplasm: OSm for tumours with strong expression of total Akt2 and pAkt Thr308-n+c vs. all other tumours was 59.2 vs. 24.1 months, P=0.006, HR 0.39, 95% CI 0.22–0.69; and it was 59.2 vs. 24.5 months, P=0.008, HR 0.45, 95% CI 0.26–0.79 for strong expression of total Akt2 and pAkt Ser473-n+c.